Skip to content

José Carlos Bouso

International Council for the Exploration of the Sea, Universitat Rovira i Virgili

94 papers in the library · 4,302 citations · publishing 0-2026

Papers

Sort Most recent Most cited

Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic

Scientific Reports September 11, 2023 José Carlos Bouso, Dóra Révész, Genís Ona et al. 9 citations

The COVID-19 pandemic has had a devastating impact on the health and wellbeing of the global population. This paper presents the results of a longitudinal transcultural study that was begun at the peak of the pandemic (in April, 2020). An online survey was used to collect data from English-, Spanish-, and Portuguese-speaking participants. The survey collected information about...

DOI: 10.1038/s41598-023-41199-x (opens in new tab) Full text (opens in new tab) Hallucinogen Psychopathology Pandemic Portuguese +5

Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey

Psychoactives June 13, 2023 Tessa Cowley-Court, Richard Chenhall, Jerome Sarris et al. 19 citations

Ayahuasca is an Amazonian psychoactive plant medicine being explored for its potential therapeutic uses in Western contexts. Preliminary studies link ayahuasca use with improvements across a range of mental health indicators, but studies have not yet explored qualitative aspects of the post-treatment process known in the psychedelic literature as “integration”. This includes how participants...

Hallucinations and Hallucinogens: Psychopathology or Wisdom?

Culture, Medicine, and Psychiatry June 1, 2023 José Carlos Bouso, Genís Ona, Maja Kohek et al. 8 citations

Hallucinations are currently associated almost exclusively with psychopathological states. While it is evident that hallucinations can indicate psychopathology or neurological disorders, we should remember that hallucinations also commonly occur in people without any signs of psychopathology. A similar case occurs in the case of hallucinogenic drugs, which have been long associated with...

DOI: 10.1007/s11013-022-09814-0 (opens in new tab) Full text (opens in new tab) Hallucinations Hallucinogens Ontology Psychedelics +2

The modern clinical use of hallucinogens. What can we learn from the natural product research?

Natural Product Research May 1, 2023 Genís Ona, Maja Kohek, José Carlos Bouso 2 citations

Can the emerging field of psychedelic research benefit from natural product research? We believe it can. In this manuscript we delineate certain topics of research with hallucinogens that directly connect with research on natural products in general.

Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies

Psychoactives March 20, 2023 Guilherme Henrique de Morais Santos, Lucas Silva Rodrigues, Juliana Mendes Rocha et al. 6 citations

Background: Ayahuasca is a serotoninergic hallucinogen that plays a central role in the Amazonian traditional medicine. Its psychoactive effects are associated with the presence of N,N-dimethyltryptamine (DMT), and monoamine oxidase inhibitors (MAO-A). Advances in neuroimaging investigations have provided insight into ayahuasca’s neurobiological mechanisms of action. Methods: Selecting only...

Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences.

Drug and Alcohol Review February 1, 2023 Borja J Rodríguez-cano, Maja Kohek, Genís Ona et al. 17 citations

Ibogaine is one of the alkaloids naturally found in plants such as Tabernanthe iboga, which has been traditionally used by members of the Bwiti culture. Since the discovery of its anti-addictive properties by Howard S. Lotsof in 1962, ibogaine has been used experimentally to treat substance use disorders (SUD), especially those involving opioids. We aim to provide a detailed understanding of...

DOI: 10.1111/dar.13587 (opens in new tab) Full text (opens in new tab) Psychedelic-assisted therapy Hallucinogenic Qualitative analysis Substance use disorders +15

Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant

Biomolecules November 2, 2022 Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker et al. 29 citations

Ayahuasca is a psychoactive brew traditionally used in indigenous and religious rituals and ceremonies in South America for its therapeutic, psychedelic, and entheogenic effects. It is usually prepared by lengthy boiling of the leaves of the bush Psychotria viridis and the mashed stalks of the vine Banisteriopsis caapi in water. The former contains the classical psychedelic...

DOI: 10.3390/biom12111618 (opens in new tab) Ayahuasca Antidepressant Hallucinogen Pharmacology +1

Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine: A new path for the Global Mental Health movement.

Transcultural Psychiatry October 1, 2022 Genís Ona, Ali Berrada, José Carlos Bouso 28 citations

The Global Mental Health (GMH) movement aims to provide urgently needed treatment to those with mental illness, especially in low- and middle-income countries. Due to the complexity of providing mental health services to people from various cultures, there is much debate among GMH advocates regarding the best way to proceed. While biomedical interventions offer some degree of help,...

Tripping to Cope: Coping Strategies and Use of Hallucinogens during the COVID-19 Pandemic in Three Cultural Contexts

Psychoactives September 2, 2022 Genís Ona, Dóra Révész, Maja Kohek et al. 9 citations

The COVID-19 pandemic has made evident the need to develop effective strategies to cushion the psychological consequences of social catastrophes. Preliminary evidence suggests that the use of hallucinogens is a protective factor that mitigates against such stressors. However, the underlying mechanisms must be further explored. This study specifically focused on the potential role of coping...

DOI: 10.3390/psychoactives1010003 (opens in new tab) Hallucinogen Coping psychology Disengagement theory Pandemic +5

Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate

Journal of Psychopharmacology August 1, 2022 Javier Hidalgo Jiménez, José Carlos Bouso 34 citations

N,N-dimethyltryptamine (DMT) is a potent psychedelic naturally produced by many plants and animals, including humans. Whether or not DMT is significant to mammalian physiology, especially within the central nervous system, is a debate that started in the early 1960s and continues to this day. This review integrates historical and recent literature to clarify this issue, giving special attention...

The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study

Cannabis and Cannabinoid Research July 26, 2022 Alberto Sainz-Cort, Daniel Jiménez‐garrido, Elena Muñoz Marrón et al. 9 citations

Background: Social cognition abilities such as empathy and the Theory of Mind (ToM) have been shown to be impaired in neuropsychiatric conditions such as psychotic, autistic, and bipolar disorders. The endocannabinoid system (ECS) seems to play a role in social behavior and emotional processing while it also seems to play a role in those neuropsychiatric conditions showing social cognition...

Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies.

European Archives of Psychiatry and Clinical Neuroscience June 1, 2022 Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha et al. 48 citations

Ayahuasca is a hallucinogenic/psychedelic traditionally used for ritual and therapeutic purposes. One such therapeutic use is related to Substance Use Disorders (SUDs). A previous systematic review of preclinical and human studies published until 2016 suggested that ayahuasca and its alkaloids have therapeutic effects in the treatment of SUDs. To conduct an update of this previous review. A...

The adverse events of ibogaine in humans: an updated systematic review of the literature (2015-2020).

Psychopharmacology June 1, 2022 Genís Ona, Juliana Mendes Rocha, José Carlos Bouso et al. 41 citations

Ibogaine is the main alkaloid of the African shrub Tabernanthe iboga. It produces hallucinogenic and psychostimulant effects, but it is currently known for the anti-addictive properties. Despite the potential therapeutic effects, several cases of fatalities and serious adverse events related to ibogaine/noribogaine use can be found in the literature. Most studies consist in case reports or were...

DOI: 10.1007/s00213-021-05964-y (opens in new tab) Full text (opens in new tab) Adverse events Drug interactions Ibogaine risks Noribogaine safety +12

Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands

Journal of Psychoactive Drugs May 28, 2022 Maja Kohek, Genís Ona, Michiel van Elk et al. 25 citations

Ayahuasca is a plant decoction in traditional Amazonian medicine. Its ritual use has been internationalized, leading to policy challenges that countries should address. This study evaluates the impact of regular ayahuasca ceremony participation on health by assessing the health status of 377 participants in ayahuasca ceremonies in the Netherlands using validated health indicators. A...

Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability

Expert Opinion on Drug Safety March 18, 2022 Giordano Novak Rossi, Isabella Caroline Da Silva Dias, Glen B. Baker et al. 17 citations

There were no reports of serious AEs, indicating a relative safety of ayahuasca administration in controlled settings. Most common AEs included nausea, vomiting, headaches, and transient increases in cardiovascular measurements. Ayahuasca research is still in its infancy, especially concerning the absence of large and robust clinical trials to verify its antidepressant effects. Dose...

DOI: 10.1080/14740338.2022.2054988 (opens in new tab) Ayahuasca Tolerability Clinical trial Adverse effect +11

Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials

Human Psychopharmacology: Clinical and Experimental February 2, 2022 Rafael G. Dos Santos, Juliana Mendes Rocha, Giordano Novak Rossi et al. 20 citations

Abstract Objective To assess endocannabinoid (anandamide, AEA; 2‐arachidonoylglycerol, 2‐AG) plasma levels in healthy volunteers and in volunteers with social anxiety disorder (SAD) after a single oral dose of ayahuasca or placebo. Methods Post hoc analysis of endocannabinoid plasma levels (baseline, 90 and 240 min after drug intake) from two parallel‐group, randomized, placebo‐controlled...

DOI: 10.1002/hup.2834 (opens in new tab) Ayahuasca Anxiety Placebo Endocannabinoid system +4

Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey.

PLOS global public health 2022 José Carlos Bouso, Óscar Andión, Jerome Sarris et al. 115 citations

Ayahuasca is a plant-based decoction native to Amazonia, where it has a long history of use in traditional medicine. Contemporary ritual use of ayahuasca has been expanding throughout the world for mental health purposes, and for spiritual and personal growth. Although researchers have been conducting clinical trials and observational studies reporting medical and psychological benefits, most...

Preliminary evidence of links between ayahuasca use and the corpus callosum.

Frontiers in Psychiatry 2022 Otto Simonsson, José Carlos Bouso, Florian Kurth et al. 6 citations

Recent research suggests that ayahuasca and its alkaloid-containing ingredients may be helpful in the treatment and prevention of certain movement and neurodegenerative disorders. However, such research is still in its infancy and more studies in normative samples seem necessary to explore effects of ayahuasca on clinically relevant brain structures, such as the corpus callosum. The purpose of...

Ancient psychoactive plants in a global village: The ritual use of cannabis in a self-managed community in Catalonia.

International Journal of Drug Policy December 1, 2021 Maja Kohek, Constanza Sánchez Avilés, Oriol Romaní et al. 14 citations

Cannabis is a plant with a rich history of medical, recreational, industrial and spiritual uses. This paper aims to explore drug use rituals as methods of community-controlled use that help maintain a self-regulated and healthy relation to the substance in questions. Furthermore, it explores how cannabis is used in developing spirituality and a sense of community. The ritual use of cannabis is...

Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts

Journal of Clinical Psychopharmacology August 20, 2021 Alberto Sainz-Cort, Daniel Jiménez‐garrido, Elena Muñoz Marrón et al. 17 citations

BACKGROUND: Although δ-9-tetrahydrocannabinol (THC), the main cannabinoid from the cannabis plant, is responsible for the psychotomimetic effects of cannabis, cannabidiol (CBD), the second most abundant cannabinoid in the cannabis plant, does not show any psychotomimetic effect. Cannabidiol has even been proposed to be antipsychotic and to counteract some of the psychotomimetic effects of THC....

Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers

Frontiers in Psychiatry August 6, 2021 Juliana Mendes Rocha, Giordano Novak Rossi, Flávia de Lima Osório et al. 37 citations

Rationale: Previous studies with the serotonergic hallucinogens LSD and psilocybin showed that these drugs induced changes in personality traits, such as increases in Openness. However, results are inconsistent, and the effects of ayahuasca on personality were never investigated in a controlled trial. Objectives: To assess the effects of ayahuasca on personality in two randomized,...

Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross‐sectional survey

Drug and Alcohol Review July 25, 2021 Daniel Perkins, Emérita Sátiro Opaleye, Hana Šimonová et al. 54 citations

Abstract Introduction Emerging evidence suggests that psychedelic compounds, including the Amazonian botanical decoction ayahuasca, may provide clinical benefit in the treatment of alcohol or other drug use disorders. This study investigates associations between ayahuasca consumption in naturalistic settings and current alcohol and other drug use. Methods Online cross‐sectional study of people...

DOI: 10.1111/dar.13348 (opens in new tab) Ayahuasca Cross-sectional study Confounding Logistic regression +2

Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder

Journal of Clinical Psychopharmacology June 23, 2021 Rafael G. Dos Santos, Flávia de Lima Osório, Juliana Mendes Rocha et al. 85 citations

Abstract Background Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing, speech). This controlled trial assessed the effects of ayahuasca on speech performance and anxiety in individuals with social anxiety disorder. Methods Seventeen volunteers with social anxiety disorder participated in...

DOI: 10.1097/jcp.0000000000001428 (opens in new tab) Ayahuasca Social anxiety Perception Audiology +3

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study

Frontiers in Psychiatry June 16, 2021 Dóra Révész, Genís Ona, Giordano Novak Rossi et al. 42 citations

Background: One of the main public health strategies adopted at the beginning of the COVID-19 pandemic consisted of implementing strict lockdowns to stop the transmission of the virus. Despite being an effective measure, the confinement and the associated social isolation create a stressful, potentially lengthy situations that has been proven to have several psychological consequences. Given...

The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study

Frontiers in Pharmacology May 5, 2021 Débora González, Jordi Cantillo, Irene Hidalgo Pérez et al. 39 citations

Promoting well-being is one of the main goals to improve health in the world. We examined the well-being and quality of life over the course of one year in a sample that participated in an Indigenous Shipibo healing program where traditional healers work in a series of ayahuasca ceremonies. We also explored the role of decentering as a mediator of psychological well-being. Participants who...

DOI: 10.3389/fphar.2021.623923 (opens in new tab) Ayahuasca Happiness Observational study Scale ratio +7